Wedbush Securities’s United Therapeutics UTHR Stock Holding History

Wedbush Securities’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$452K	Buy	+835	New	+$470K	0.01%	759
2020 Q3	–	Sell	-2,310	Closed	-$280K	–	1019
2020 Q2	$280K	Hold	2,310	–	–	0.03%	637
2020 Q1	$219K	Sell	2,310 -1,000	-30%	-$95K	0.03%	645
2019 Q4	$292K	Sell	3,310 -700	-17%	-$61.6K	0.03%	690
2019 Q3	$320K	Sell	4,010 -200	-5%	-$16.1K	0.03%	612
2019 Q2	$329K	Buy	4,210 +700	+20%	+$65.5K	0.03%	595
2019 Q1	$412K	Sell	3,510 -200	-5%	-$23.3K	0.04%	481
2018 Q4	$404K	Hold	3,710	–	–	0.05%	425
2018 Q3	$474K	Sell	3,710 -500	-12%	-$61.8K	0.05%	418
2018 Q2	$476K	Buy	4,210 +500	+13%	+$55K	0.06%	394
2018 Q1	$417K	Hold	3,710	–	–	0.05%	414
2017 Q4	$549K	Hold	3,710	–	–	0.07%	345
2017 Q3	$435K	Buy	+3,710	New	+$474K	0.06%	428
2017 Q2	–	Sell	-1,500	Closed	-$203K	–	872
2017 Q1	$203K	Hold	1,500	–	–	0.03%	681
2016 Q4	$215K	Buy	+1,500	New	+$192K	0.03%	643

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Wedbush Securities's UTHR Position: Q2 2026 in Review

Wedbush Securities opened a new position in United Therapeutics (UTHR) in Q2 2026: 835 shares worth $452K. The stake represents 0.01% of the portfolio and ranks #759 among its holdings. This is a return to the name: Wedbush Securities previously reported a position in UTHR as recently as Q2 2020.

Wedbush Securities first reported a position in UTHR in Q4 2016 and has held it in 15 quarters since. The position peaked at $549K in Q4 2017. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Wedbush Securities held 835 shares of United Therapeutics worth $452K as of Q2 2026.
United Therapeutics was a new Wedbush Securities position in Q2 2026.
United Therapeutics made up 0.01% of Wedbush Securities's portfolio in Q2 2026, its #759 holding.
Wedbush Securities first reported a position in United Therapeutics in Q4 2016 and has held it in 15 quarters since.
Wedbush Securities's United Therapeutics position peaked at $549K in Q4 2017.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.